Currently the Enterprise Value (EV) is not available for BeOne Medicines.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 1.8,
with a Debt / Equity ratio of 0.32.
1.8
1.58
0.32
-2.72
-1.61
0
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$346.39K
$-58.62K
11,000
0.64
1.2
Taxes
111.78M
-20.97%
Stock Price Statistics
The stock price has increased by 78.65% in the
last 52 weeks. The beta is 0.21, so BeOne Medicines's
price volatility has been higher than the market average.
0.21
78.65%
290.13
244.41
65.48
387,130
Income Statement
In the last 12 months, BeOne Medicines had revenue of 3.81B
and earned -644.79M
in profits. Earnings per share was -6.12.